Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05168267 · ClinicalTrials.gov registry record · NA

PTSD Treatment for Incarcerated Men and Women: NIMH

A NA study of PTSD, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
69
Enrollment target
1
Study location

NCT05168267 is a NA study of PTSD that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 69 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05168267, a NA study of PTSD, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target
1
Study location

Study Summary

Study examining the feasibility of and psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will be conducted in male and female incarcerated populations and will include 2 groups of 10 individuals for CPT in both populations (i.e., 40 participants total; 20F/20M). The study will run for up to 2 years. Participants can expect to be participating in study for up to 22 weeks.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Processing Therapy

Study Locations (1)

Wisconsin

  • Psychiatric Institute and Clinic - Madison

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2022-06-06
Est. Completion 2024-07-31
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05168267

The ClinicalTrials.gov registry entry for NCT05168267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (77% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Processing Therapy is the first listed.

NCT05168267 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05168267 about?

NCT05168267 is a clinical study titled "PTSD Treatment for Incarcerated Men and Women: NIMH". Study examining the feasibility of and psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will be conducted in male and female incarcerated populations and will include 2 groups of 10 individuals for ...

What is the current status of trial NCT05168267?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2022-06-06. Estimated completion is 2024-07-31.

What conditions does trial NCT05168267 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT05168267?

The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05168267?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05168267 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.